| Literature DB >> 35932021 |
Masahiro Fukada1, Katsutoshi Murase2, Toshiya Higashi2, Seito Fujibayashi2, Masashi Kuno2, Itaru Yasufuku2, Yuta Sato2, Shigeru Kiyama2, Yoshihiro Tanaka2, Naoki Okumura2, Nobuhisa Matsuhashi2, Takao Takahashi2.
Abstract
BACKGROUND: Postoperative pancreatic fistula (POPF) is one of the serious complications of pancreatic surgery. When POPF occurs and becomes severe, it causes secondary complications and a longer treatment period. We previously reported a correlation between pancreatic fibrosis and magnetic resonance imaging (MRI) findings, and MRI may have the potential to predict POPF. This study aimed to assess the predictive ability of the pancreas-to-muscle signal intensity ratio on T1-weighted MRI (SIR on T1-w MRI) for POPF after distal pancreatectomy (DP).Entities:
Keywords: Distal pancreatectomy; Postoperative pancreatic fistula; Signal intensity ratio on T1-weighted MRI
Mesh:
Substances:
Year: 2022 PMID: 35932021 PMCID: PMC9354425 DOI: 10.1186/s12957-022-02718-8
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 3.253
Fig. 1Exclusion criteria
Fig. 2Analysis flow chart for identifying predictive factors for postoperative pancreatic fistula (POPF) after distal pancreatectomy (DP)
Fig. 3The pancreas-to-muscle signal intensity ratio on fat-suppressed axial T1-weighted MRI was calculated by [signal intensity of the pancreatic parenchyma] (arrow)/[signal intensity of the paraspinal muscle] (arrowhead)
Comparison of clinical outcomes between patients with and without POPF after distal pancreatectomy
| Patients with POPF ( | Patients without POPF ( | |||
|---|---|---|---|---|
| Diagnosis days of POPF (day) | 7 (3–25) | - | - | |
| Grade of POPFa | - | |||
| Grade B | 27 (93.1) | - | ||
| Grade C | 2 (6.9) | - | ||
| Treatment for POPF | ・Drain replacement and irrigation | 19 (65.5) | - | - |
| ・Endoscopic transgastric drainage | 7 (24.1) | |||
| ・Antibiotics and octreotide | 3 (10.4) | |||
| Postoperative death within 30 days | 2 (6.9) | 0 (0.0) | 0.06 | |
| Hospital days (days) | 35 (12–121) | 13 (7–23) | <0.01✝ | |
Data are expressed as median (range) or number of patients (percentage)
POPF Postoperative pancreatic fistula
aInternational Study Group (ISGPS) definition and grading of POPF as follows: grade B, symptomatic fistula requiring therapeutic intervention such as antibiotics and percutaneous drainage; grade C, symptomatic fistula associated with a severe general condition of patients, sepsis, and multiorgan failure requiring aggressive treatment in the intensive care unit and surgical intervention
✝p < 0.05
Comparison of pre-, intra-, and postoperative status between patients with and without POPF after distal pancreatectomy
| Patients with POPF | Patients without POPF | |||
|---|---|---|---|---|
| Preoperative | Age (years) | 67 (40–82) | 67 (11–84) | 0.87 |
| Sex | ||||
| Male | 18 (62.1) | 50 (56.8) | 0.67 | |
| Female | 11 (37.9) | 38 (43.2) | ||
| BMI (kg/m2) | 23.6 (17.6–32.2) | 22.4 (16.2–32.2) | 0.37 | |
| Pancreatic ductal adenocarcinoma | 12 (41.4) | 43 (48.9) | 0.53 | |
| Location | ||||
| Body | 14 (48.3) | 54 (61.4) | 0.28 | |
| Tail | 15 (51.7) | 34 (38.6) | ||
| Pancreas-to-muscle SIR on T1-w MRI | 1.64 (1.25–2.68) | 1.35 (0.74–2.16) | <0.01✝ | |
| Intraoperative | Operative time (min) | 284 (174–537) | 264 (143–564) | 0.13 |
| Blood loss (ml) | 190 (10–1910) | 260 (0–1840) | 0.84 | |
| Surgical procedure | ||||
| Open | 23 (79.3) | 60 (68.2) | 0.35 | |
| Laparoscopic | 6 (20.7) | 28 (31.8) | ||
| Spleen preserving | 3 (10.3) | 15 (17.1) | 0.56 | |
| Non-spleen preserving | 26 (89.7) | 73 (82.9) | ||
| Resection procedure | ||||
| Hand-sewn | 11 (37.9) | 36 (40.9) | 0.83 | |
| Stapler | 18 (62.1) | 52 (59.1) | ||
| Pancreas texture | ||||
| Soft | 21 (72.4) | 54 (61.4) | 0.37 | |
| Hard | 8 (27.6) | 34 (38.6) | ||
| Pancreas thickness (mm) | 11 (8–17) | 12 (3–24) | 0.46 | |
| Postoperative | D-Amy levels (U/l) | |||
| POD 1 | 7652 (108–34076) | 1899 (42–61075) | 0.02✝ | |
| POD 3 | 1290 (42–16515) | 403 (35–43873) | <0.01✝ | |
| WBC (×103/μl) | ||||
| POD 1 | 12.6 (7.5–26.5) | 11.1 (5.3–18.2) | <0.01✝ | |
| POD 3 | 13.3 (5.9–26.9) | 11.3 (3.9–23.9) | 0.048✝ | |
| CRP (mg/dl) | ||||
| POD 1 | 9.3 (1.8–15.4) | 8.3 (0.2–17.5) | 0.16 | |
| POD 3 | 20.1 (8.0–33.5) | 14.5 (0.3–26.5) | <0.01✝ | |
| Body temperature (°C) | ||||
| POD 1 | 38.0 (37.1–39.4) | 38.0 (36.9–39.3) | 0.55 | |
| POD 3 | 37.4 (36.1–38.9) | 37.4 (36.2–39.4) | 0.30 | |
| Heart rate (bpm) | ||||
| POD 1 | 98 (81–142) | 92 (61–122) | 0.07 | |
| POD 3 | 88 (72–111) | 82 (56–119) | <0.01✝ | |
Data are expressed as median (range) or number of patients
POPF Postoperative pancreatic fistula, BMI Body mass index, pancreas-to-muscle SIR on T-w MRI the pancreas-to-muscle signal intensity ratio on unenhanced T1-weigthed magnetic resonance imaging, D-Amy drainage fluid amylase concentration, POD Postoperative day, WBC White blood cell, CRP C-reactive protein
✝p< 0.05
Fig. 4Receiver operating characteristic (ROC) curve analysis of pancreas-to-muscle SIR on T1-weighted MRI and D-Amy level on POD 1 and 3 for discriminating to POPF
Uni- and multivariate predictive factors of POPF after DP
| Univariate | Multivariate | |||||||
|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||||
| Preoperative | Age (years) | |||||||
| >70 | 45 | 0.79 | 0.32–1.89 | 0.61 | ||||
| <70 | 72 | 1 | ||||||
| Sex | ||||||||
| Male | 68 | 1.24 | 0.53–3.01 | 0.62 | ||||
| Female | 49 | 1 | ||||||
| BMI (kg/m2) | ||||||||
| >24 | 39 | 2.07 | 0.85–5.00 | 0.10 | ||||
| <24 | 77 | 1 | ||||||
| Pancreatic ductal adenocarcinoma | ||||||||
| Yes | 55 | 0.74 | 0.31–1.72 | 0.48 | ||||
| No | 62 | 1 | ||||||
| Location | ||||||||
| Body | 68 | 0.59 | 0.25–1.37 | 0.22 | ||||
| Tail | 49 | 1 | ||||||
| Pancreas-to-muscle SIR on T1-w MRI | ||||||||
| >1.37 | 61 | 29.7 | 5.83–543.73 | <0.01✝ | 23.25 | 3.93–454.03 | <0.01✝ | |
| <1.37 | 41 | 1 | 1 | |||||
| Intraoperative | Operative time (min) | |||||||
| >300 | 38 | 1.36 | 0.55–3.24 | 0.50 | ||||
| <300 | 78 | 1 | ||||||
| Blood loss (ml) | ||||||||
| >400 | 39 | 0.86 | 0.33–2.07 | 0.73 | ||||
| <400 | 77 | 1 | ||||||
| Surgical procedure | ||||||||
| Open | 83 | 1.79 | 0.69–5.28 | 0.24 | ||||
| Laparoscopic | 34 | 1 | ||||||
| Spleen preserving | 18 | 0.56 | 0.12–1.87 | 0.37 | ||||
| Non-spleen preserving | 99 | 1 | ||||||
| Resection procedure | ||||||||
| Hand-sewn | 47 | 0.88 | 0.36–2.07 | 0.78 | ||||
| Stapler | 70 | 1 | ||||||
| Pancreas texture | ||||||||
| Soft | 75 | 1.65 | 0.68–4.35 | 0.28 | ||||
| Hard | 42 | 1 | ||||||
| Pancreas thickness (mm) | ||||||||
| >12 | 56 | 0.71 | 0.30–1.64 | 0.42 | ||||
| <12 | 61 | 1 | ||||||
| Postoperative | D-Amy levels (U/l)—POD 1 | |||||||
| >7238 | 33 | 5.07 | 2.07–12.78 | <0.01✝ | 1.21 | 0.31–4.75 | 0.78 | |
| <7238 | 83 | 1 | 1 | |||||
| D-Amy levels (U/l)—POD 3 | ||||||||
| >737 | 51 | 4.99 | 2.04–13.25 | <0.01✝ | 3.91 | 1.02–16.36 | 0.046✝ | |
| <737 | 65 | 1 | 1 | |||||
| WBC (×103/μl)—POD 1 | ||||||||
| >1.20 | 48 | 3.16 | 1.34-7.75 | <0.01✝ | 2.44 | 0.69–9.12 | 0.17 | |
| <1.20 | 69 | 1 | 1 | |||||
| WBC (×103/μl)—POD 3 | ||||||||
| >1.40 | 34 | 2.59 | 1.07–6.29 | 0.04✝ | 1.03 | 0.27–3.73 | 0.96 | |
| <1.40 | 83 | 1 | 1 | |||||
| CRP (mg/dl)—POD 1 | ||||||||
| >10 | 40 | 1.51 | 0.63–3.58 | 0.35 | ||||
| <10 | 77 | 1 | ||||||
| CRP (mg/dl)—POD 3 | ||||||||
| >20 | 34 | 3.89 | 1.61–9.60 | <0.01✝ | 2.75 | 0.75–10.70 | 0.13 | |
| <20 | 83 | 1 | 1 | |||||
| Body temperature (°C)—POD 1 | ||||||||
| >38.0 | 71 | 0.74 | 0.32–1.75 | 0.49 | ||||
| <38.0 | 46 | 1 | ||||||
| Body temperature (°C)—POD 3 | ||||||||
| >38.0 | 14 | 0.47 | 0.07–1.87 | 0.31 | ||||
| <38.0 | 103 | 1 | ||||||
| Heart rate (bpm)—POD 1 | ||||||||
| >100 | 38 | 2.05 | 0.85–4.88 | 0.11 | ||||
| <100 | 79 | 1 | ||||||
| Heart rate (bpm)—POD 3 | ||||||||
| >100 | 13 | 4.35 | 1.32–14.81 | 0.02✝ | 3.84 | 0.77–21.40 | 0.10 | |
| <100 | 104 | 1 | 1 | |||||
POPF Postoperative pancreatic fistula, OR Odds ratio, 95% CI 95% Confidence interval, BMI Body mass index, pancreas-to-muscle SIR on T-w MRI the pancreas-to-muscle signal intensity ratio on unenhanced T1-weigthed magnetic resonance imaging, D-Amy drainage fluid amylase concentration, POD Postoperative day, WBC White blood cell, CRP C-reactive protein
✝p < 0.05